ECL: FY25 Deep Dive
FY25 revenue $16.08B (+2.2%) — operating income $2.91B (+11%); net income $2.08B (-2%); diluted EPS $7.28 (-1%). FCF $1.90B (+5%). Buybacks $784M (-21% from FY24). Total debt $9.4B (+$1.1B). JPM upgraded N→OW (March 24); BNP raised $345 (largest); Wells Fargo trim to $285 (low); Citi $345→$330 trim.
Key Takeaways
Ecolab closed fiscal 2025 (calendar year ended December 31, 2025) at $16.08 billion of revenue, up 2.2% YoY. Operating income $2.91 billion (+11%); net income $2.08 billion ($7.28 diluted EPS). Free cash flow $1.90 billion (+5%). The structural read: continued Pricing Excellence + Innovation execution lifting operating margin from 16.6% (FY24) to 18.1% in FY25 — the +150bp expansion is the cleanest in specialty chemicals. Capital allocation: $754M dividends + $784M buybacks (-21% from FY24's $987M). Total debt $9.4B (+$1.1B). Sell-side coverage in Feb-April 2026 window: JPMorgan upgraded Neutral → Overweight on March 24 (PT held at $295, then later to $290); BNP Paribas raised to $345 (largest); BMO + Citi at $345 (Street-high tier); Wells Fargo trim $310 → $285 (low). Pattern: mostly bullish PT raises + 1 upgrade.
Main business structure
Ecolab reports three operating segments:
| Segment | Approx FY25 Share |
|---|---|
| Industrial | ~50% (water, F&B, paper, energy, mining) |
| Institutional & Specialty | ~30% (foodservice, hospitality, healthcare, life sciences) |
| Healthcare & Life Sciences | ~10% |
| Pest Elimination | ~10% |
Industrial: water treatment + cleaning chemicals for industrial customers. Largest segment.
Institutional: foodservice + hospitality cleaning programs.
Pricing power + innovation drive durable margin expansion.
Key core metrics (3-year trend)
| FY23 | FY24 | FY25 | |
|---|---|---|---|
| Revenue ($B) | 15.32 | 15.74 | 16.08 |
| YoY | — | +2.7% | +2.2% |
| Operating income ($B) | 2.16 | 2.61 | 2.91 |
| Net income ($B) | 1.37 | 2.11 | 2.08 |
| Diluted EPS | $4.79 | $7.37 | $7.28 |
| Operating margin | 14.1% | 16.6% | 18.1% |
| FCF ($B) | 1.64 | 1.82 | 1.90 |
| Buybacks ($M) | 14 | 987 | 784 |
Market evaluation
Sell-side coverage (Feb-April 2026):
- JPMorgan: upgraded N → Overweight on March 24 — the structural rating change
- BNP Paribas: $330 → $345 Feb 12 — Outperform, Street-high tier
- BMO Capital: $323 → $345 Feb 13 — OP
- Citi: $324 → $345 → $330 cumulative — Buy maintained
- Stifel: $300 → $337 — Buy
- Jefferies: $315 → $352 (highest)
- Wells Fargo: $310 → $285 cumulative — EW maintained, Street-low
Buy-side positioning. ECL is core specialty chemicals holding paired with SHW, IFF, FMC. Trades at premium multiple on margin expansion track record.
FY25 corporate structure: pricing-led margin expansion + capital return
FY25 was another year of Ecolab's "Pricing Excellence + Innovation" template producing margin expansion (+150bp to 18.1%). Revenue +2.2%, operating income +11%, FCF +5%. The JPM upgrade + broadly bullish PT direction reflect Street's view that the margin expansion will continue. The Q1 FY26 earnings print this week is the proximate event.